Accelerating Medicines Partnership - Alzheimer's Disease

preview_player
Показать описание
The Accelerating Medicines Partnership Alzheimer’s Disease Project (AMP-AD) is a precompetitive partnership among government, industry, and nonprofit organizations that focuses on discovering novel, clinically relevant therapeutic targets and on developing biomarkers to help validate existing therapeutic targets.
  1. FNIH
  2. AMP AD
  3. Accelerating Medicines Partnership
  4. Alzheimer's
  5. Alzheimer's disease
  6. AD
Рекомендации по теме
Accelerating Medicines Partnership 0:04:21

Accelerating Medicines Partnership - Alzheimer's Disease

AMP® Symposium Day 1:14:00

AMP® Symposium Day 1: Alzheimer's Disease

AMP® Alzheimer's Disease 0:05:50

AMP® Alzheimer's Disease

FDA grants accelerated 0:02:09

FDA grants accelerated approval for new Alzheimer's drug

FDA Approved New 0:00:54

FDA Approved New Alzheimer Drug in 2023 | Living Minute

Trove of Alzheimer’s 0:02:28

Trove of Alzheimer’s patients’ molecular, clinical data available

Accelerating Population Research 0:55:18

Accelerating Population Research and its Impact on Reducing Alzheimer’s Disease Burden

C-Path Supports Alzheimer's 0:00:31

C-Path Supports Alzheimer's and Brain Awareness Month - END ALZ Campaign

Alzheimer's Disease 2021: 0:38:52

Alzheimer's Disease 2021: Hot Topics in Disease Prevention and Clinical Trials

Finding Solutions for 0:51:05

Finding Solutions for Alzheimer's Disease Through Translational Research at IU School of Medici...

FDA considering accelerated 0:02:42

FDA considering accelerated approval of new Alzheimer’s drug

Implications of Aducanumab, 0:58:38

Implications of Aducanumab, the New Alzheimer's Drug with Gil Rabinovici and Rita Redberg

Expanding the Target 1:22:39

Expanding the Target Landscape in Alzheimer's Disease through Open Science - 21 September 2021

Progress on Treatment 0:53:42

Progress on Treatment for Alzheimer's

NIA Small Business 1:22:38

NIA Small Business Funding: Accelerating Alzheimer's and Aging Research (with Audio Description...

Webinar: CMS's Coverage 1:48:52

Webinar: CMS's Coverage Decision: It's Not Just About Alzheimer's Disease

Howard Fillit, MD 0:01:28

Howard Fillit, MD - Exec. Director & Chief Science Officer, Alzheimer's Drug Discovery Foun...

Should the FDA 1:00:06

Should the FDA Have Approved the New Alzheimer’s Drug?

The Science of 1:36:48

The Science of Alzheimer's Disease & Latest Research Developments

FDA approves new 0:02:49

FDA approves new Alzheimer's drug | FOX 9 KMSP

Penn Drug Discovery 0:04:06

Penn Drug Discovery Team Finds Potential Alzheimer's Disease Drug

Approval and Reimbursement 1:01:33

Approval and Reimbursement of Alzheimer’s Disease Therapies

Grant Creates IU 0:01:35

Grant Creates IU Alzheimer's Center

Session 2: Microbes 1:40:36

Session 2: Microbes and Alzheimer's Disease: Bridging Silos to Accelerate Innovation Symposium ...